Correlation Between CTBC Financial and SynCore Biotechnology

Can any of the company-specific risk be diversified away by investing in both CTBC Financial and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTBC Financial and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CTBC Financial Holding and SynCore Biotechnology Co, you can compare the effects of market volatilities on CTBC Financial and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTBC Financial with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTBC Financial and SynCore Biotechnology.

Diversification Opportunities for CTBC Financial and SynCore Biotechnology

-0.87

Correlation Coefficient

CTBC Financial  SynCore Biotechnology

Pay attention - limited upside

The 3 months correlation between CTBC and SynCore is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding CTBC Financial Holding and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and CTBC Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTBC Financial Holding are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of CTBC Financial i.e., CTBC Financial and SynCore Biotechnology go up and down completely randomly.

Pair Corralation between CTBC Financial and SynCore Biotechnology

Assuming the 90 days trading horizon CTBC Financial Holding is expected to generate 0.9 times more return on investment than SynCore Biotechnology. However, CTBC Financial Holding is 1.12 times less risky than SynCore Biotechnology. It trades about 0.26 of its potential returns per unit of risk. SynCore Biotechnology Co is currently generating about -0.13 per unit of risk. If you would invest  3,255  in CTBC Financial Holding on September 13, 2024 and sell it today you would earn a total of  655.00  from holding CTBC Financial Holding or generate 20.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CTBC Financial Holding  vs.  SynCore Biotechnology Co

CTBC Financial Holding

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in CTBC Financial Holding are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, CTBC Financial showed solid returns over the last few months and may actually be approaching a breakup point.

SynCore Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with CTBC Financial and SynCore Biotechnology

The main advantage of trading using opposite CTBC Financial and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTBC Financial position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.

The idea behind CTBC Financial Holding and SynCore Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.